Efficacy and safety of vismodegib in advanced basal-cell carcinoma Academic Article uri icon

Overview

MeSH Major

  • Anilides
  • Antineoplastic Agents
  • Carcinoma, Basal Cell
  • Hedgehog Proteins
  • Pyridines
  • Skin Neoplasms

abstract

  • Vismodegib is associated with tumor responses in patients with locally advanced or metastatic basal-cell carcinoma. (Funded by Genentech; Erivance BCC ClinicalTrials.gov number, NCT00833417.).

publication date

  • June 7, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5278761

Digital Object Identifier (DOI)

  • 10.1056/NEJMoa1113713

PubMed ID

  • 22670903

Additional Document Info

start page

  • 2171

end page

  • 9

volume

  • 366

number

  • 23